R&D

News

Merdad Parsey will leave Gilead next year

Gilead Sciences' chief medical officer, Merdad Parsey, will leave the company in early 2025, becoming the latest in a series of high-profile departures involving senior R&D figures at t

R&D

Clinical development rates are falling - but it’s not all ba...

Over the past decade, a shift has been occurring in biopharma R&D.

News

AbbVie's new chief scientific officer Roopal Thakkar (l), who is replacing Thomas Hudson (r)

AbbVie lines up Thakkar to replace outgoing CSO Hudson

There is change at the top of AbbVie’s R&D organisation, as chief scientific officer Thomas Hudson announces his retirement after four years in the role.

News

Mikael Dolsten exits Pfizer, putting R&D leadership in flux

Pfizer’s chief scientific officer and president of R&D, Mikael Dolsten, has said he will step down from the role in the coming months, kicking off the search for a successor.

News

Human stem cell-based embryo model – Blastoids. Blue marks all nuclei, the green label marks cells of the inner cell mass, and the pink label is a readout of a ribosomal protein.

UK gets guidance on synthetic human embryos for research

A new code of practice has been drawn up in the UK to try to make sure that research on human embryo models derived from stem cells is carried out ethically and responsibly.

News

FDA reveals diversity action plan guide for clinical trials

The FDA has published its long-awaited update to guidance to make sure clinical trials more closely reflect the range of patients that might be treated with a new therapy in the real world.

Merdad Parsey will leave Gilead next year

Clinical development rates are falling - but it’s not all ba...

AbbVie lines up Thakkar to replace outgoing CSO Hudson

Mikael Dolsten exits Pfizer, putting R&D leadership in flux

UK gets guidance on synthetic human embryos for research

FDA reveals diversity action plan guide for clinical trials

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

R&D

Editor's Picks